Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.

A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer

Published version of a preprint

Abstract

Purpose: The molecular drivers of antitumor immunity in pancreatic ductal adenocarcinoma (PDAC) are poorly understood, posing a major obstacle for the identification of patients potentially amenable for immune-checkpoint blockade or other novel strategies. Here, we explore the association of chemokine expression with effector T-cell infiltration in PDAC. Experimental Design: Discovery cohorts comprised 113 primary resected PDAC and 107 PDAC liver metastases. Validation cohorts comprised 182 PDAC from The Cancer Genome Atlas and 92 PDACs from the Australian International Cancer Genome Consortium. We explored associations between immune cell counts by immunohistochemistry, chemokine expression, and transcriptional hallmarks of antitumor immunity by RNA sequencing (RNA-seq), and mutational burden by whole-genome sequencing. Results: Among all known human chemokines, a coregulated set of four (CCL4, CCL5, CXCL9, and CXCL10) was strongly associated with CD8+ T-cell infiltration (P < 0.001). Expression of this “4-chemokine signature” positively correlated with transcriptional metrics of T-cell activation (ZAP70, ITK, and IL2RB), cytolytic activity (GZMA and PRF1), and immunosuppression (PDL1, PD1, CTLA4, TIM3, TIGIT, LAG3, FASLG, and IDO1). Furthermore, the 4-chemokine signature marked tumors with increased T-cell activation scores (MHC I presentation, T-cell/APC costimulation) and elevated expression of innate immune sensing pathways involved in T-cell priming (STING and NLRP3 inflammasome pathways, BATF3-driven dendritic cells). Importantly, expression of this 4-chemokine signature was consistently indicative of a T-cell–inflamed phenotype across primary PDAC and PDAC liver metastases. Conclusions: A conserved 4-chemokine signature marks resectable and metastatic PDAC tumors with an active antitumor phenotype. This could have implications for the appropriate selection of PDAC patients in immunotherapy trials.

Overview

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-19-2803

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 84 references

Research works printed but not linked: 1

  1. Cameron, 2013, Cytokines, chemokines and their receptors [book on the Internet], Madame Curie Biosci Database

Cited by

See all 146

Metadata

Authors
Romero, J. M., Grünwald, B., Jang, G.-H., Bavi, P. P., Jhaveri, A., Masoomian, M., Fischer, S. E., Zhang, A., Denroche, R. E., Lungu, I. M., De Luca, A., Bartlett, J. M. S., Xu, J., Li, N., Dhaliwal, S., Liang, S.-B., Chadwick, D., Vyas, F., Bronsert, P., Khokha, R., McGaha, T. L., Notta, F., Ohashi, P. S., Done, S. J., O'Kane, G. M., Wilson, J. M., Knox, J. J., Connor, A., Wang, Y., Zogopoulos, G., & Gallinger, S.
Affiliations
  • Ontario Institute for Cancer Research (CA)
  • University Health Network (CA)
  • 5Diagnostic Development, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • University of Freiburg (DE)
  • Research Institute of the McGill University Health Centre (CA)
  • 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Venue
Clinical Cancer Research
Published
2020-04-15
Volume
26
Issue
8
Pages
1997-2010
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W3002753972
Cited by
146
References
84
Citations by year
2026: 12 · 2025: 14 · 2024: 30 · 2023: 31 · 2022: 32 · 2021: 21 · 2020: 5
FWCI
8.03
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Friends of the Hebrew University
  • Pancreatic Cancer Canada Foundation
  • Lebovic Chair in Hepatobiliary
  • pancreatic Surgical Oncology
  • Canadian Institutes of Health Research (ALTF 116-2018)
  • Alexander von Humboldt Foundation (DEU 1199182)
Topics
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords
pancreatic ductal adenocarcinoma, carbon tetrachloride, RANTES, CXCL9, CXCL10, CD8+ T cell infiltration, antitumor immunity, liver metastasis, immune checkpoint blockade, T cell activation, immunosuppression, STING pathway, NLRP3 inflammasome, Batf3, dendritic cells, mutational burden, immunotherapy patient selection
MeSH terms
RNA-Seq, Immune Checkpoint Proteins, Humans, Immunotherapy, Liver Neoplasms, Mutation, Pancreatic Neoplasms, Biomarkers, Tumor, Cohort Studies, CD8-Positive T-Lymphocytes, Chemokine CCL5, Computational Biology, Databases, Genetic, Chemokine CXCL10, Chemokine CXCL9, Chemokine CCL4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-19-2803
The paper
Romero, J. M., Grünwald, B., Jang, G.-H., Bavi, P. P., Jhaveri, A., Masoomian, M., Fischer, S. E., Zhang, A., Denroche, R. E., Lungu, I. M., De Luca, A., Bartlett, J. M. S., Xu, J., Li, N., Dhaliwal, S., Liang, S.-B., Chadwick, D., Vyas, F., Bronsert, P., . . . Gallinger, S. (2020). A Four-Chemokine Signature Is Associated with a T-cell–Inflamed Phenotype in Primary and Metastatic Pancreatic Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-2803

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.